GSTC 0.00 GlobeStar Therapeutics Corporation
| Range: | 2.0E-4-0.0027 | Vol Avg: | 12786189 | Last Div: | 0 | Changes: | 0 |
| Beta: | 1.55 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Mon Sep 26 2011 | Empoloyees: | |||
| CUSIP: | 37960P104 | CIK: | 0001502152 | ISIN: | US37960P1049 | Country: | US |
| CEO: | Mr. James C. Katzaroff | Website: | https://www.globestarthera.com | ||||
GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. The company was incorporated in 2016 and is based in Richland, Washington.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow